http://rdf.ncbi.nlm.nih.gov/pubchem/patent/UA-130788-U

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1cbb5ffce9642fc9e93f061835c459b7
classificationIPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P39-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-047
filingDate 2018-06-12-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2018-12-26-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber UA-130788-U
titleOfInvention METHOD OF TREATMENT OF ENDOGENIC INTOXICATION SYNDROME OF PURPLE-SEPTIC GENESIS
abstract A method of treating endogenous purulent-septic genesis syndrome involves administering an intensive care complex and administering sorbitol infusion at a rate of 6-7 ml / kg bw intravenously at a rate of 7-8 ml / min. Additionally, infusion of 4.2% solution of L-arginine intravenously drip at an initial speed of 10 drops / min, and after 20 minutes the speed can be increased to 30 drops / min. The total duration of administration of L-arginine 1.5 h.
priorityDate 2018-06-12-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419585166
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID82170
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6322
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419537902
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419490943
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5780

Total number of triples: 17.